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ABSTRACT  
Background Evidence for longer-term exercise delivery for people with Parkinsons Disease 
(pwP) is deficient.   
Aim Evaluate safety and adherence to a minimally supported community exercise 
intervention and estimate effect sizes (ES). 
Methods Two arm parallel phase II randomised controlled trial with blind assessment. PwP 
able to walk ≥100meters and with no contraindication to exercise were recruited from the 
Thames valley, UK and randomised (1:1) to intervention (exercise) or control (handwriting) 
groups, via a concealed computer-generated list. Groups received a six month, twice weekly 
program. Exercise was undertaken in community facilities (30minutes aerobic and 
30minutes resistance) and handwriting at home, both were delivered through workbooks 
with monthly support visits. Primary outcome was a 2minute walk, with motor symptoms 
(MDS-UPDRS III), fitness, health and wellbeing measured.   
 Results  Between December 2011 and August 2013,  n=53  (n=54 analysed) were allocated 
to exercise and n=52 (n=51 analysed) to handwriting. n=37 adhered to the exercise, most 
attending ≥1 session/week. Aerobic exercise was performed in 99% of attended sessions 
and resistance in 95%. Attrition and adverse events (AE) were similar between groups, no 
Serious AEs (n=2 exercise, n=3 handwriting) were related, exercise group related AEs (n=2) 
did not discontinue intervention. Largest effects were for motor symptoms (2minute walk 
ES= 0.20 (95%CI=-0.44:0.45) and MDS-UPDRS III ES=-0.30 (95%CI=0.07:0.54)) in favour of 
exercise over the 12month follow-up period. Some small effects were observed in fitness 
and wellbeing measures (ES >0.1).  
Conclusion pwP exercised safely and the possible long-term benefits observed support a 
substantive evaluation of this community program.(ClinicalTrials.Gov:NCT01439022). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Short term exercise has been shown to benefit or stop deterioration in symptoms offering 
potential personal, societal and economic benefits for the management of Parkinson’s 
disease (PD),[1 2] but many people with Parkinson’s disease (PwP) undertake less exercise 
than other age-matched people, and less than recommended to maintain good health.[3, 4] 
Whilst exercise may improve health and wellbeing and reduce motor and non-motor 
symptoms in PwP,[3-6] there is a lack of evidence for the long-term benefits.[6-10] This is in 
part due to the difficulties of effectively delivering exercise over the longer-term; existing 
researched interventions are predominantly not cost-effective or sustainable.[11] Thus 
there is a need for more evidence on how to best deliver a solution that is effective long 
term. 
 
 Exercise referral schemes run throughout the UK are standardised, widely commissioned 
and have been shown to be effective for cardiac conditions and older people offering a 
pragmatic solution for PwP.[12, 13] However, PwP are underrepresented within standard 
UK exercise referral schemes, [14, 15] and report significant barriers.[16]  
 
With the help of fitness professionals, PwP and clinicians, a supported self-managed  
community exercise program for people with long-term neurological conditions was 
developed to fit within existing community fitness centres delivered in gyms by professional 
with expertise in clinical exercise.[17, 18] The intervention was guided by behaviour change 
theory that considered an individual’s capability, opportunity and motivation and 
incorporated appropriate evidence for safe effective exercise and self-determination theory. 
[16-19] In this phase II exploratory trial, we evaluated the program’s utility focusing on the 
extent to which people safely participated and adhered to the six month exercise program. 
We also sought to estimate effects sizes on fitness, motor and non-motor symptoms, and 
health and wellbeing measures.   
 
METHODS: 
DESIGN 
A two arm parallel single blind phase II randomised controlled trial of community delivered 
exercise for pwP. Participants recruited to the study were allocated the next available study 
number by the blinded assessor. The study number related to a computer-generated 
randomization list drawn up by the Oxford Primary Care Clinical Trials Unit (Nuffield 
Department of Primary Care Health Sciences) that randomized individuals (1:1) into either 
intervention (Exercise) or control groups (handwriting). The randomisation list used 
minimisation to balance groups for gender and whether or not individuals used medication 
for PD at baseline. The list was held by the principal investigator who informed those 
supporting the intervention of group allocation. Group allocation was concealed from the 
assessor until the end of the study.    
 
SETTING  
Participants were recruited from Oxfordshire, Berkshire and Buckinghamshire, UK and 
assessments were carried out at the Movement Science Laboratory, Oxford Brookes 
University, Oxford, UK.  
 
 PARTICIPANTS  
The study received National Health Service ethical approval (NRES Committee South Central 
- Southampton A: 11/SC/0267), was registered with ClinicalTrials.Gov (NCT01439022), and 
was conducted in accordance with the declaration of Helsinki. 
People with idiopathic PD were recruited from neurology clinics at the John Radcliffe, Royal 
Berkshire and Heatherwood and Wexham Park hospitals (via the Dementias and 
Neurodegeneration research network), GP practices (via Thames Valley Primary Care 
Research Network) and though local Parkinson’s UK meetings.  
Inclusion criteria were: (i) diagnosis of idiopathic PD (as defined by the UK PD Society Brain 
Bank criteria);[20] (ii) able to walk ≥100 meters (with or without walking aid). Exclusion 
criteria were: (i) A diagnosis of dementia; (ii) history of additional prior neurological 
condition; (iii) severe depression or psychosis or a mental state that would preclude 
consistent active involvement with the study over its duration; (iv) cardiac precautions that 
would prevent the subject from participating in the intervention; (v) any known 
contraindication to exercise; (vi) reduced cognitive function of any cause (mini-mental state 
examination <23); (vii) an orthopaedic condition that limited independent walking. 
Participants’ medication was continued as normal and was recorded.  
INTERVENTION  
Supplement 1 contains details of the intervention according to TIDiER Guidelines.[21] 
Briefly, both the intervention (exercise) and control groups (handwriting) were prescribed 
activity sessions lasting 60minutes twice a week over a period of six months. After the six 
month assessment no further instruction for exercise (or handwriting practice) was given.  
 Exercise group  
 The exercise sessions took place at community leisure facilities in Oxfordshire and Berkshire 
and were supported by monthly visits from a professional experienced in clinical exercise. 
The exercise program was delivered through an exercise booklet and consisted of 
30minutes of aerobic training (55-85% age predicted heart rate max (220-age)) followed by 
30minutes of resistance training.   
 
Handwriting group  
The handwriting sessions took place in the participants home and were supported by 
monthly visits by the same staff that supported exercise sessions. The program was 
delivered through handwriting workbooks and consisted of ‘warm-up’ hand exercises 
followed by a variety of writing exercises, finishing with hand exercises.   
 
ASSESSMENT  
Demographic information, medical history relating to PD, including current medication use, 
and cognition (mini-mental state examination) was ascertained at the baseline assessment.    
All outcome measures were performed at baseline (entry), 3months (halfway intervention), 
6months and (end intervention) and 12months. Measurements were made by the same 
assessor blinded to intervention allocation and trained in the Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS).[22] If a patient had On and Off 
periods, assessments were carried out during ON state.  Participants followed their usual 
Parkinson’s medication regime, but were asked to refrain from the consumption of alcohol, 
cigarettes, food and caffeine and to avoid exercise for a period of three hours prior to the 
assessment.  
 
Outcome Measures 
A detailed description of outcome measures can be found in the supplement 1.  
 
Motor: The primary outcome measure was the 2minute walk test.[23]  Mobility was also 
measured using the timed up and go test (TUG),[23] and dexterity using the 9 hole peg 
test[24]. Global motor function was assessed using the motor examination of the MDS-
UPDRS (III).[25]   
 
Fitness:  Aerobic fitness was determined using a stepwise incremental exercise test. The 
work rate protocol consisted of 2minute steps starting with unloaded cycling, then 
increasing to 50watts, and thereafter by 25watts. Participants were verbally encouraged to 
carry on for as long as they could and the test was terminated when the participant reached 
volitional exhaustion. Rate of oxygen consumption was calculated as the average oxygen 
consumed over the last 30secs of the test (VO2max l.min-1).[26] Leg power was measured 
using a ‘power meter’,[27] the maximum power achieved from each leg separately was 
recorded and reported as an average. Grip strength was measured using a hand held 
dynometer, the maximum force of each hand was recorded and reported as the average. 
[28]  
 
Health and wellbeing: Health related quality of life was measured using the Euro-QOL 
(EQ5D-5L)[29] and SF36,[30] scores are reported for the EQ5D-5L index score and SF36 
physical and mental scores. Non-motor symptoms were assessed using the Parkinson’s 
disease non-motor symptom questionnaire[31] and self-reported fatigue using the Fatigue 
Severity Scale (FSS).[32] Health status was measured using  Body Mass Index and resting 
blood pressure and physical activity using the Physical Activity Scale for the Elderly.[33] 
 
Intervention fidelity  
Adherence and fidelity was obtained from the exercise booklets. For aerobic exercise, time 
(in minutes) and exercise equipment used was reported, along with rating of perceived 
Exhaustion (RPE) and heart rate at the end of the exercise. Resistance training was recorded 
as the weight (kg) used for the exercise and the number of the repetitions for each exercise, 
with training volume calculated (weight (kg) x number of repetitions). Engagement with the 
control intervention was determined by number of handwriting session attempted.   
Data analysis  
Whilst this was a phase II trial and not designed to determine efficacy, sample size was 
based on the estimated effect on 2minute walk distance.  To detect a clinically meaningful 
change of 12meters in the 2minute walk would require an effect size of 0.55, with a power 
of 80% and alpha of 0.05, 80 participants (40 in each group) would be required.  Allowing for 
attrition, we aimed to recruit a total of 100 participants.  
 Data were analysed based on the intention-to-treat principle. Descriptive statistics were 
calculated for demographic characteristics and compliance data. Independent samples T-
test or X2 test was used to assess differences between group mean and frequencies at 
baseline. Progression in training volume was investigated using linear regression in SPSS 
(v19). For outcome data the Linear Mixed Models (LMM) procedure of SAS 9.4 was used to 
determine the mean changes in measures, as response variables, according to two 
intervention regimes (exercise and handwriting) and three repeated measurements, using 
baseline as a covariate. Further and based on the differences of least square (Marginal) 
means between two groups (exercise vs. handwriting) provided by LMM analysis, powers, 
effect sizes (Cohen’s d) and their 95% non-central confidence limits were calculated.  
 
 
RESULTS 
Recruitment, randomisation and participant flow  
Between December 2011 and August 2013 the trial recruited 105 participants within the 
proposed time line.  We could not record the number of people screened in the eight GP 
surgeries and PD Clinics (John Radcliffe, Royal Berkshire and Heatherwood 
and Wexham Park Hospitals) or the total number of people informed of the study via either 
presentation at group meetings or newsletter articles at seven local Parkinson’s UK groups 
(Oxford, Newbery, Bracknell, Wokingham, Reading, Hazlemere and High Wycombe). The 
study was also promoted on Parkinson’s UK and Michael J Fox websites.   
In total 170 people, contacted through one or more of these routes, expressed an interest in 
the study; 107 were assessed for eligibility with only two not meeting criteria, leaving 105 
people.  Table 1 shows pre intervention assessment data, whilst there was no statistical 
difference between groups, scores for 2minute walk and MDS-UPDRS III tended to be better 
in the exercise group. Only one person, in the exercise group, used a walking aid. VO2 data 
was unavailable on eleven people from each group due to contraindications. One 
participant did not receive the allocated intervention, allocated to handwriting group but 
received exercise, and was included in analysis as part of exercise group. The allocations 
error was due a misunderstanding of the allocation by the staff delivering intervention. The 
error was discovered after the completion of the intervention.  
Attrition after randomisation was similar between groups, and participant flow can be found 
in figure 1. Two people were excluded after randomisation (1 from each group) for no 
longer meeting eligibility criteria due to a revised/additional diagnosis (Lewy-body 
dementia, multiple system atrophy). Retention was similar between groups with ≥80% 
retention for both groups at the 3month and 6months dropping to 67% in the exercise 
group and 63% in handwriting group at 12months. Unrelated medical reasons were the 
main cause of lost to follow-up at the primary (6month) assessment point. Most of these 
occurred prior to the 3month appointment resulting in participants dropping out of the trial.  
Five participants experienced serious adverse events (n=2 exercise group, n=3 handwriting 
group) during the trial, these were deemed unrelated to either intervention (fall resulting in 
hospitalisation n=2, acute pancreatitis n=1, death n=2).   
Intervention fidelity. 
Exercise group: In total 17 individuals discontinued intervention (figure 1), 8 individuals due 
to medical reasons and one individual was excluded due to additional diagnosis of Lewy-
Body dementia. Participants were deemed to have discontinued intervention if they 
attended none or only the initial session (n=9), reasons can be found in figure 1. There were 
two related adverse events; these were an abnormal heart rate response to exercise and 
orthostatic hypotension, both participants continued with the intervention following 
medical clearance.  All discontinued intervention occurred within the first 3months.  
Intervention fidelity was further investigated in the 37 participants that did not discontinue 
the exercise program. Most people (n=32) attended one or more sessions a week on 
average and  the median number of session attended was 40 out of the 48 prescribed 
sessions.  
In 1341 out of the 1350 sessions attended (99%) the aerobic component was performed for 
a mean (SD)  time of 30.2 (± 3.6) minutes per session.  The exercise bike was the most 
popular mode of aerobic exercise (676 sessions), followed by treadmill (353 sessions) and 
mixed modes (309 sessions), cross trainer or rowing machine made up ~1% of sessions.  The 
mean (SD) heart rate during the aerobic component was 116 ± 20 bpm with 93% of aerobic 
sessions performed with in the target zone.  
 Considering the resistance component; in 95% of attended sessions the two arm pull down 
exercise was performed, 93% arm raises, 91% leg press, 85% sit-to-stands, 80% ‘wood chop’ 
and 25% leg extensions. Linear regression revealed a significant increase (p<0.05) in 
resistance training volume (resistance weight x number of repetitions) during the exercise 
program for all exercise except arm raises. Beta co-efficient indicated two arm pull down 
resistance training volume increased by 3.0 (SE 0.7) kg per session (R2 0.12, p <0.0001), leg 
press volume 10.0 (SE 1.1) kg per session (R2 0.24, p<0.0001), sit to stand 2.7 (SE 0.3) kg per 
session (R2 0.20, p<0.0001), ‘wood chop’ 2.3 (SE 0.66) kg per session (R2 0.10, p<0.0001) and 
leg extension volume 1.7 (SE 0.6) kg per session (R2 0.08, p=0.04).  
Handwriting group: In total 11 individuals had discontinued intervention by the 6month 
follow-up, most did not given a reason (n=6) and there were three discontinued 
intervention due to medical reasons (figure 1). Two SAE were recorded that did not result in 
discontinue intervention; a fall that occurred during the intervention and a death which 
occurred after the intervention in the follow-up period. There were no related adverse 
events in the handwriting group. The median number of handwriting sessions performed 
was 40 out of the 48 prescribed sessions and most people (n=36) did more than one session 
a week on average. 
Outcome  
Follow-up assessments were completed September 2014. Outcome data is reported in table 
2, small to moderate effect sizes (0.1 – 0.3) were found for a number of outcomes.[34] 
Effect sizes are between group and considered all three follow-up assessments, the largest 
effect was found on MDS-UPDRS III -0.30 (95%CI 0.07:0.54) which was significantly lower at 
the primary endpoint (end intervention) in the exercise group (p<0.005) indicating an 
improvement in motor symptoms.  2minute walk distance, the primary outcome measure, 
produced the second largest effect 0.20 (95%CI -0.44:0.45), in favour of the intervention 
group, with the largest difference found between groups at 12months (p<0.063).  Small 
effects were found for improvement in leg power and  aerobic capacity fitness parameters 
and in perceived health related quality of life health (EQ5D-5L visual analogue scale and 
SF36  physical subscale). Effects that favoured the control group were found for non-motor 
symptoms and fatigue. For the above measures the direction of effect was consistent over 
all 3 assessment points.     
  
DISCUSSION 
People with PD will use community leisure facilities to undertake exercise delivered through 
an exercise booklet supported by a professional with expertise in clinical exercise. 
Furthermore, our data is encouraging that six month intervention seems to lead to 
improvements in mobility and motor symptoms that are sustained over a year.  Although 
the exercise program was not fully adhered to by all, most patients became engaged with 
the exercise program, and these potential long-term benefits were observed with intention-
to-treat analysis. There were no serious adverse events related to the exercise and, after 
investigation, all individuals that had related adverse event were able to continue with the 
intervention. Essentially most patients, after receiving instructions to initiate the program, 
were able to largely self-manage their exercise, achieving and progressing the prescribed 
exercise, with minimal support.  As such our study establishes that the use of community 
exercise facilities is feasible to achieve long-term gains for pwP.  
The effects we observed compare favourably to those reported in systematic reviews.  A 
meta-analysis of aerobic training, primarily driven by studies with short interventions and 
follow-ups (less than 16weeks), found a pooled mean difference in MDS-UPDRS III of -
0.57(95%CI –0.95:0.19) in favour of exercise,[1] we found a difference of -3.0±1.5, -4.0±1.4 
and -1.5±1.6 at 3, 6 and 12months respectively. Uhrbrand et al[2] found in their review that 
improvements in the MSD-UPDRS III were more associated with resistance than aerobic 
exercise modes. Our exercise program incorporated both aerobic and resistance exercise 
and combining training modalities may be important to optimise benefits.[2] However, 
whilst individuals progressed, we did not observe the improvements in aerobic and 
resistance fitness measures that might be expected.[1, 2] It is therefore plausible that the 
improvements in motor symptoms observed might be to some extent attributable to 
exercise-induced neuroplasticity identified in animal models of the disease,[35] rather than 
just improved physical capacity.  This supports the need for studies designed to distinguish 
improvements in physical capacity from any possible neuroplasticity effects.   
 
These findings should be interpreted considering limitations. It should be recognised that 
the study was not designed to determine efficacy and the number of patients was not large, 
reducing the precision of estimating the size of any benefit. We also used a control group 
that received a handwriting intervention in order to engage people through the study 
period, participant flow indicates that this was successfully achieved and indicates a desire 
for interventions to address handwriting problem in this group. However, the engagement 
of the control group may have diluted the effects found. Overall physical activity levels did 
not differ between groups and both groups increased physical activity levels from baseline. 
This may have particularly impacted on health and wellbeing measures that reflect multiple 
factors, indeed, effects for non-motor symptoms and fatigue favoured the control group. In 
Multiple Sclerosis the effect of exercise on fatigue has received considerable research 
attention and whilst individuals may have to balance rest and activity to participate in 
exercise,[36] exercise is recommended to benefit this symptom.[37] Currently there is 
insufficient evidence to inform fatigue management in Parkinson’s. [6]      However, we did 
observe, albeit small, potential positive effects on quality of life. This is encouraging as 
systematic reviews have not established improvements in this construct despite the 
improvements in motor symptoms.[1 2]  Certainly, while systematic reviews supports that 
exercise interventions can benefit PwP and are safe,[1, 2, 7, 38] they also confirm that the 
longer-term effects have not been established and that pragmatic delivery models are 
largely untested.[3-6, 39, 40] We propose that the intervention provides evidence for 
effectively supporting PwP to engage with an exercise program for six months through 
standard community resources. The adherence to the program compares favourably to  
adherence to standard UK exercise referral,[41] with 69% of our participants adhering to the 
exercise program and 86% of these individuals attending more than 1 session a week on 
average compared with a pooled rate of 37% (95%CI 20%:54%) for exercise referral. There 
was also excellent compliance to the exercise program content and there was good 
evidence demonstrating that individuals progressed through the program, in terms of 
increasing training volume.  
 
Considering our intervention, individuals participated safely in the community supported 
exercise program. The eligibility criteria and participant screening and monitoring were 
effective in selecting people suitable for the intervention. However, this group may present 
or develop co-existing pathology that can affect their ability to exercise and medical reasons 
were the predominant reason for discontinue intervention. We found most issues effecting 
exercise participation could be safely managed either directly by the practitioner supporting 
the intervention or through advice from or referral to appropriate medical professionals, 
highlighting the role of appropriately trained professionals to support and guild self-
managed community exercise programs.  Importantly a National Occupational Standards, 
for supporting exercise in people with neurological conditions are available for professional 
education.  
 
It should be considered that, whilst we used a wide range of recruitment routes methods 
reducing the risk of recruitment bias, participants were recruited from Oxfordshire, 
Berkshire and Buckinghamshire, which are affluent areas of the UK. Acknowledging this 
limitation we nevertheless propose the findings are largely generalizable to relatively 
healthy PwP.  Therefore, the intervention represents a sustainable viable exercise program 
for supporting PwP in community leisure venues across the UK, which could be 
implemented through existing exercise referral systems. The fundamental components of 
the intervention and delivery model could also be applied or adapted to other healthcare 
systems and conditions.  Pwp in England have higher rates of emergency admissions with 
longer hospital stays, higher costs (£907 million over four years) and in-hospital mortality; 
with many of the issues secondary to inactivity.[21] Thus, PD is a good model for developing 
community clinical exercise programs suitable for other neurological/degenerative 
conditions and, as such, the study has application to another three million individuals. The 
information gained from this research remain highly relevant and important to the needs of 
the public health services to adapt both to the ageing demographic and to people living 
longer with long-term neurological conditions. 
 
In summary at present the evidence indicates that patients can be informed that attending a 
leisure centre to undertake this program carries minimal risk and may improve or maintain 
motor symptoms. A substantive evaluation including wider geography, longer follow-up and 
cost effectiveness is now indicated in order to determine whether this technology should be 
taken up by the NHS and would significantly add to the scientific knowledge of the cost 
effectiveness of longer-term exercise for this group. This technology has the potential to be 
implemented in the UK and worldwide.  
 
 
 Table 1: Baseline characteristic and pre intervention assessment data   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean±SD, Delta = between group difference (Exercise – Handwriting) ± Standard error of difference reported 
with p value of independent samples T test, for nominal data p value for X2 statistic reported.. Abbreviations: 
MMSE = mini-mental State Examination; MOA-B = Monoaomine oxidase type B; COMT = catechol-O-methyl 
transferase; MDS-UPDRS III = Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III; TUG 
= Timed up and go test; EQ5D-5L (VAS) index score of the Euro-QOL EQ5D-5L; SF36= Short form (36 item) 
health survey, physical and mental sub scores; N-MSQ= Parkinson’s disease non-motor symptom 
questionnaire; FSS = fatigue severity scale; BMI = Body mass index (Weight (kg)/ (height(m) 2); MAP BP= mean 
arterial Blood pressure ((Systolic blood pressure (mm Hg) + 2 x Diastolic blood pressure(mm Hg) / 3)); PASE = 
Physical Activity Scale for the Elderly. 
 
       
 
 Exercise Handwriting Delta (p) 
Demographics  n=54 n=51  
Age (years) 66±9 67±7 -2±2 (0.307) 
Gender (M:F) 31:23 30:21 X2 (0.883) 
MMSE 29±1 29±1 0±0 (0.882) 
Time since diagnosis 4.8±4.1 5.3±4.1 -0.5±0.8 (0.547) 
On PD Medication (Y:N) 52:2 47:4  
Levodopa n=39 n=30  
Dopamine agonists n=25 n=29  
Anticholinergics n=2 n=3  
MOA-B inhibitors n=14 n=14  
COMT inhibitors n=2 n=1  
Motor Symptoms    
2 minute walk test (m) 146.6±23.9 137.7±22.9 8.8±4.6 (0.061) 
UPDRS part III  16.7±10.1 19.9±9.9 -2.4±2.0 (0.214) 
9 hole peg test (sec) 24.9±5.4 26.8±5.9 -1.9±1.1 (0.089) 
TUG (sec) 9.4±2.0 10.1±2.1 -0.7±0.4 (0.069) 
Fitness    
VO2 (l.min
-1)  1.65±0.64(n=43) 1.49±0.53 (n=40) 0.17±0.13 (0.205) 
Leg power (watts) 84±36 76±36 8±7 (0.257) 
Grip strength (watts) 31±10 31±10 -0±2 (0.915) 
Health and wellbeing     
EQ5D-5L 76±15.4 75±15 0±3 (0.903) 
SF36- physical 64±18 61±19 3±4 (0.397) 
SF36- metal 71±17 68±17 2±3 (0.470) 
N-MSQ 8.4±5.0 8.6±4.2 -0.2±0.9 (0.118) 
FSS 3.6±1.4 3.9±1.4 -0.32±0.28 (0.261) 
BMI 26.8±5.2 26.7±4.1 0.1±0.9 (0.908) 
MAP BP (mmHg) 100±12 94±19 6±3 (0.054) 
PASE 66±35 61±35 5±8 (0.519) 
 
Table 2: Outcome  
 
 
Least squares means ± Standard error estimates, delta = between group difference (Exercise – Handwriting), Effect size = Cohen’s d based on least squares (marginal) 
means differences over all assessments with non-central 95% Confidence Intervals. Abbreviations:  MDS-UPDRS III = Movement Disorder Society Unified Parkinson’s 
Disease Rating Scale part III; TUG = Timed up and go test; EQ5D-5L (VAS) index score of the Euro-QOL EQ5D-5L; SF36= Short form (36 item) health survey, physical and 
mental sub scores; N-MSQ= Parkinson’s disease non-motor symptom questionnaire; FSS = fatigue severity scale; BMI = Body mass index (Weight (kg)/ (height(m) 2); MAP 
BP= mean arterial Blood pressure ((Systolic blood pressure (mm Hg) + 2 x Diastolic blood pressure(mm Hg) / 3)); PASE = Physical Activity Scale for the Elderly      
 
 3month 6month 12month Effect size 
 Exercise Handwriting Delta Exercise Handwriting Delta  Exercise Handwriting Delta  d (95%CI) 
Motor Symptoms           
2 minute walk test (m) 145.7±2.4 141.9±2.4 3.8±3.5  146.3±2.4 142.9±2.4 3.4±3.5  144.6±2.5 137.9±2.6 6.7± 3.6  0.20 (-0.44:0.45) 
MDS-UPDRS III  14.7±1.1 17.7±1.1 -3.0±1.5  14.1±1.0 18.1±1.0 -4.0±1.4  17.7±1.1 19.2±1.2 -1.5± 1.6  -0.30 (0.07:0.54) 
9 hole peg test (sec) 26.4±0.6 26.0±0.6 0.4±0.8  25.6±0.6 25.6±0.6 -0.1±0.8  26.2±0.6 25.7±0.6 0.5±0.8  0.05 (-0.19:0.30) 
TUG (sec) 9.8± 0.3 9.8± 0.3 -0.1± 0.4  9.9±0.3 9.8± 0.3 0.1± 0.4  10.1±0.3 10.6± 0.3 -0.5± 0.4  -0.06 (0.00:0.30) 
Fitness           
Aerobic (VO2max: l.min
-1)  1.59±0.05 1.58±0.05 0.01±0.07  1.63± 0.05 1.55±0.05 0.09±0.07  1.57±0.05 1.53±0.06 0.04±0.08  0.10 (-0.19:0.30) 
Leg power (watts) 148±7 136±7 12±10  152±7 137±7 15±10  143±7 128±7 15±10  0.19 (-0.06:0.45) 
Grip strength (kg) 29±1 30±1 -1±2  29±1 29±1 -1±2  33±1 30±2 3±2  0.03 (-0.21:0.27) 
Health and wellbeing            
EQ5D-5L (VAS) 76±2 75±2 1±3  78±2 74±2 3±3  76±2 74±2 2±3  0.12 (-0.12:0.36) 
SF36- physical 64±2 63±2 1±3  62±2 61±2 1±3  62±3 58±3 4±4  0.10 (-0.14:0.34) 
SF36- metal 72±2 71± 2 1±3  70±2 68±2 2±3  68±3 66± 3 2± 4  0.08 (-0.16:0.32) 
N-MSQ 8.2±0.4 7.7±0.4 0.5± 0.6  8.6± 0.4 8.0± 0.4 0.6± 0.6  8.9± 0.4 8.0± 0.4 0.9±0.6  0.19 (-0.06:0.43) 
FSS 3.7±0.1 3.3±0.1 0.4±0.20  3.5±0.1 3.3±0.1 0.1±0.2  3.6±0.1 3.4±0.2 0.1± 0.2  0.18 (-0.07:0.42) 
BMI 26.5±0.1 26.4±0.1 0.1±0.2  26.4±0.2 26.2±0.2 0.1±0.2  26.4±0.3 26±0.3 0.2±0.4  0.08 (-0.17:0.32) 
MAP BP (mm)Hg) 89±2 93±2 -3±3  91±2 92±2 -1±3  88±3 89±3 -1± 4  -0.09 (0.00:0.33) 
PASE 79±7 74±8 5±11  77±6 79±6 -2±9  58±6 62±7 -5±8   -0.01 (0.00:0.74) 
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